We are live on !
Find out more
Alexandria Capital Portfolio holdings
AUM
$1.08B
Turnover
6.69%
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter Est. Return
-0.02%
1 Year Est. Return
+29.48%
3 Year Est. Return
+66.81%
5 Year Est. Return
+126.74%
10 Year Est. Return
–
AUM
$1.08B
AUM Growth
+$1.6M
(+0.15%)
Cap. Flow
-$10.6M
Cap. Flow % of AUM
Cap. Flow %
-0.98%
Top 10 Holdings %
Top 10 Hldgs %
25.11%
Holding
269
New
3
Increased
97
Reduced
102
Closed
15
Avg Time Held
Equity + Options
4.6
years
Top 10 Avg Time Held
Equity + Options
2.9
years
Top 20 Avg Time Held
Equity + Options
2.8
years
Avg Time Held Equity only
4.6
years
Top 10 Avg Time Held Equity only
2.9
years
Top 20 Avg Time Held Equity only
2.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$1.59M |
| 2 |
State Street SPDR Portfolio Short Term Treasury Index ETF
SPTS
|
+$1.36M |
| 3 |
Johnson & Johnson
JNJ
|
+$1.1M |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$890K |
| 5 |
State Street SPDR Portfolio Aggregate Bond Index ETF
SPAB
|
+$848K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$651K |
| 2 |
iShares MSCI India Small-Cap ETF
SMIN
|
+$555K |
| 3 |
Apple
AAPL
|
+$506K |
| 4 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$482K |
| 5 |
Nektar Therapeutics
NKTR
|
+$430K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.23% |
| 2 | Technology | 20.34% |
| 3 | Healthcare | 9.51% |
| 4 | Communication Services | 9% |
| 5 | Financials | 7.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Adobe
ADBE
$92.4B
| $72.1M | 6.67% |
125,155
-114
| -0.1% | -$71.8K |
2013 Q2
33 quarters
|
|
2
State Street SPDR S&P 500 ETF Trust
SPY
$801B
| $30M | 2.77% |
69,805
-563
| -0.8% | -$248K |
2013 Q2
33 quarters
|
|
|
3
Apple
AAPL
$5.14T
| $27.9M | 2.58% |
196,983
-3,440
| -2% | -$506K |
2013 Q2
33 quarters
|
|
|
4
Alnylam Pharmaceuticals
ALNY
$20.6B
| $23.1M | 2.14% |
122,216
-3,473
| -3% | -$651K |
2017 Q4
15 quarters
|
|
|
5
State Street SPDR Portfolio Short Term Treasury Index ETF
SPTS
$7.36B
| $21.5M | 1.99% |
700,468
+44,404
| +7% | +$1.36M |
2019 Q1
10 quarters
|
|
6
State Street SPDR Portfolio S&P 500 ETF
SPYM
$183B
| $21.2M | 1.96% |
420,116
-659
| -0.2% | -$34.2K |
2017 Q4
15 quarters
|
|
7
Vanguard Morningstar Mega Cap Growth ETF
MGK
$32.7B
| $20.1M | 1.86% |
427,020
-1,860
| -0.4% | -$90K |
2013 Q2
33 quarters
|
|
8
Alphabet (Google) Class C
GOOG
$3.53T
| $20M | 1.85% |
150,000
+40
| +0% | +$5.52K |
2015 Q4
23 quarters
|
|
9
Microsoft
MSFT
$3.94T
| $18.4M | 1.7% |
65,236
-3
| -0% | -$873 |
2013 Q2
33 quarters
|
|
10
Meta Platforms (Facebook)
META
$1.63T
| $17.1M | 1.58% |
50,420
-396
| -0.8% | -$143K |
2013 Q2
33 quarters
|
|
|
11
State Street SPDR Portfolio Aggregate Bond Index ETF
SPAB
$10.2B
| $16.8M | 1.55% |
562,120
+28,120
| +5% | +$848K |
2018 Q2
13 quarters
|
|
12
Comcast
CMCSA
$87.8B
| $16.5M | 1.53% |
294,758
-612
| -0.2% | -$35.7K |
2013 Q2
33 quarters
|
|
13
JPMorgan Chase
JPM
$907B
| $14.5M | 1.34% |
88,535
-341
| -0.4% | -$53.5K |
2013 Q2
33 quarters
|
|
14
Marvell Technology
MRVL
$147B
| $14.3M | 1.33% |
237,767
-598
| -0.3% | -$35.8K |
2020 Q1
6 quarters
|
|
15
Vanguard Short-Term Corporate Bond ETF
VCSH
$45.7B
| $12.9M | 1.2% |
157,023
+9,538
| +6% | +$788K |
2013 Q2
33 quarters
|
|
16
Invesco QQQ Trust
QQQ
$464B
| $12.5M | 1.16% |
34,975
-659
| -2% | -$243K |
2013 Q2
33 quarters
|
|
17
SBA Communications
SBAC
$20B
| $11.9M | 1.11% |
36,141
-413
| -1% | -$143K |
2017 Q4
15 quarters
|
|
18
Thermo Fisher Scientific
TMO
$267B
| $11.5M | 1.07% |
20,137
-244
| -1% | -$134K |
2015 Q2
25 quarters
|
|
19
Berkshire Hathaway Class B
BRK.B
$1.23T
| $11.5M | 1.06% |
42,090
-464
| -1% | -$130K |
2013 Q2
33 quarters
|
|
20
Cheniere Energy
LNG
$60B
| $11.1M | 1.03% |
113,612
+2,410
| +2% | +$211K |
2020 Q1
6 quarters
|
|
21
Eli Lilly
LLY
$1.27T
| $10.9M | 1.01% |
47,116
-10
| -0% | -$2.47K |
2015 Q4
23 quarters
|
|
22
Salesforce
CRM
$177B
| $10.8M | 1% |
39,768
+430
| +1% | +$109K |
2013 Q2
33 quarters
|
|
23
Nike
NKE
$56.9B
| $10.8M | 1% |
74,190
-116
| -0.2% | -$18.9K |
2013 Q2
33 quarters
|
|
24
Broadcom
AVGO
$1.67T
| $10.7M | 0.99% |
219,650
+3,660
| +2% | +$178K |
2018 Q2
13 quarters
|
|
25
Williams Companies
WMB
$84.8B
| $10.6M | 0.98% |
407,450
+4,165
| +1% | +$105K |
2018 Q2
13 quarters
|
|
Similar funds
Alexandria Capital's Q3 2021 Portfolio in Review
As of Q3 2021, Alexandria Capital held 269 positions worth $1.08B, up 0.15% from $1.08B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Alexandria Capital's Q3 2021 filing shows 3 new, 97 increased, 102 reduced and 15 closed positions. Its largest new stake was Illinois Tool Works: 1,032 shares worth $213K. The largest sale was Alnylam Pharmaceuticals, an estimated $651K.
By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, up from 38% a quarter earlier, followed by Technology and Healthcare.
- Alexandria Capital's largest Q3 2021 buy was Illinois Tool Works: 1,032 shares worth $213K.
- Alexandria Capital added most to iShares MSCI Emerging Markets ex China ETF in Q3 2021, an estimated $1.59M increase.
- Alexandria Capital's biggest Q3 2021 reduction was Alnylam Pharmaceuticals, cutting an estimated $651K.
- Alexandria Capital fully exited Nektar Therapeutics in Q3 2021, selling an estimated $430K.
- Alexandria Capital's ten largest holdings make up 25% of its $1.08B portfolio in Q3 2021.
- Alexandria Capital opened 3 new positions and closed 15 in Q3 2021.
- Alexandria Capital's portfolio value rose 0.15% quarter-over-quarter to $1.08B.
Based on Alexandria Capital's 13F filing for Q3 2021, filed 2 Dec 2021.